ANDA 86220, held by Gd Searle LLC. Potassium Chloride.
As of Nov 15, 2026, ANDA 86220 (Potassium Chloride), held by Gd Searle LLC, was not approved, with 1 approved supplement and 0 published complete response letters.
| Potassium Chloride3MEQ/ML · injectable;injection | Potassium Chloride | Discontinued |
| Potassium Chloride2MEQ/ML · injectable;injection | Potassium Chloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1982 | Supplement 4Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
